published in the September 2024 issue of Oncology by O’Brien et al. Resistance to neoadjuvant chemoradiation therapy (neo-CRT) presents a substantial clinical challenge in the management of locally ...
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...